Bank of America’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.9M | Buy |
811,939
+455,802
| +128% | +$25.4M | ﹤0.01% | 1690 |
|
|
2025
Q4 | $19.9M | Sell |
356,137
-3,947
| -1% | -$205K | ﹤0.01% | 2307 |
|
|
2025
Q3 | $17.3M | Sell |
360,084
-300,684
| -46% | -$13.4M | ﹤0.01% | 2757 |
|
|
2025
Q2 | $26.8M | Sell |
660,768
-39,403
| -6% | -$1.58M | ﹤0.01% | 2266 |
|
|
2025
Q1 | $30.7M | Buy |
700,171
+443,653
| +173% | +$19.6M | ﹤0.01% | 2026 |
|
|
2024
Q4 | $11M | Sell |
256,518
-22,425
| -8% | -$1.02M | ﹤0.01% | 2854 |
|
|
2024
Q3 | $12.4M | Sell |
278,943
-28,806
| -9% | -$1.23M | ﹤0.01% | 2874 |
|
|
2024
Q2 | $12.2M | Sell |
307,749
-33,868
| -10% | -$1.37M | ﹤0.01% | 2742 |
|
|
2024
Q1 | $14.7M | Sell |
341,617
-213,802
| -38% | -$9.21M | ﹤0.01% | 2590 |
|
|
2023
Q4 | $23.1M | Buy |
555,419
+396,934
| +250% | +$15M | ﹤0.01% | 2013 |
|
|
2023
Q3 | $6.3M | Sell |
158,485
-16,432
| -9% | -$695K | ﹤0.01% | 3193 |
|
|
2023
Q2 | $7.17M | Sell |
174,917
-118,656
| -40% | -$4.9M | ﹤0.01% | 3039 |
|
|
2023
Q1 | $12M | Sell |
293,573
-29,834
| -9% | -$1.25M | ﹤0.01% | 2636 |
|
|
2022
Q4 | $13.2M | Buy |
323,407
+44,871
| +16% | +$1.87M | ﹤0.01% | 2406 |
|
|
2022
Q3 | $11.2M | Buy |
278,536
+31,901
| +13% | +$1.36M | ﹤0.01% | 2498 |
|
|
2022
Q2 | $10.4M | Buy |
246,635
+65,939
| +36% | +$2.77M | ﹤0.01% | 2661 |
|
|
2022
Q1 | $8.18M | Sell |
180,696
-37,852
| -17% | -$1.66M | ﹤0.01% | 3059 |
|
|
2021
Q4 | $10.1M | Sell |
218,548
-34,660
| -14% | -$1.64M | ﹤0.01% | 2920 |
|
|
2021
Q3 | $12M | Sell |
253,208
-21,240
| -8% | -$1.06M | ﹤0.01% | 2650 |
|
|
2021
Q2 | $14.2M | Buy |
274,448
+100,487
| +58% | +$5.05M | ﹤0.01% | 2464 |
|
|
2021
Q1 | $8.76M | Sell |
173,961
-2,412
| -1% | -$129K | ﹤0.01% | 2854 |
|
|
2020
Q4 | $9.18M | Sell |
176,373
-11,805
| -6% | -$565K | ﹤0.01% | 2557 |
|
|
2020
Q3 | $8.18M | Sell |
188,178
-8,934
| -5% | -$391K | ﹤0.01% | 2447 |
|
|
2020
Q2 | $8.47M | Buy |
197,112
+22,655
| +13% | +$936K | ﹤0.01% | 2361 |
|
|
2020
Q1 | $6.29M | Sell |
174,457
-539,087
| -76% | -$23M | ﹤0.01% | 2461 |
|
|
2019
Q4 | $32.6M | Sell |
713,544
-307,307
| -30% | -$12.2M | ﹤0.01% | 1474 |
|
|
2019
Q3 | $36.3M | Buy |
1,020,851
+890,618
| +684% | +$33.1M | 0.01% | 1348 |
|
|
2019
Q2 | $5.19M | Sell |
130,233
-25,524
| -16% | -$1M | ﹤0.01% | 3201 |
|
|
2019
Q1 | $6.48M | Sell |
155,757
-135,395
| -47% | -$5.5M | ﹤0.01% | 2904 |
|
|
2018
Q4 | $10.7M | Sell |
291,152
-24,404
| -8% | -$1.04M | ﹤0.01% | 2239 |
|
|
2018
Q3 | $15.3M | Buy |
315,556
+5,580
| +2% | +$264K | ﹤0.01% | 2065 |
|
|
2018
Q2 | $13.3M | Sell |
309,976
-43,730
| -12% | -$1.84M | ﹤0.01% | 2161 |
|
|
2018
Q1 | $14.8M | Sell |
353,706
-76,958
| -18% | -$3.35M | ﹤0.01% | 2041 |
|
|
2017
Q4 | $18.7M | Sell |
430,664
-77,751
| -15% | -$3.31M | ﹤0.01% | 1856 |
|
|
2017
Q3 | $21.6M | Buy |
508,415
+2,668
| +0.5% | +$113K | ﹤0.01% | 1803 |
|
|
2017
Q2 | $21.8M | Buy |
505,747
+73,482
| +17% | +$3.1M | ﹤0.01% | 1657 |
|
|
2017
Q1 | $18.1M | Sell |
432,265
-161,652
| -27% | -$6.59M | ﹤0.01% | 1844 |
|
|
2016
Q4 | $23.2M | Buy |
593,917
+161,405
| +37% | +$6.57M | 0.01% | 1565 |
|
|
2016
Q3 | $19.1M | Sell |
432,512
-30,151
| -7% | -$1.37M | ﹤0.01% | 1673 |
|
|
2016
Q2 | $19.3M | Buy |
462,663
+67,816
| +17% | +$2.87M | ﹤0.01% | 1610 |
|
|
2016
Q1 | $15.9M | Sell |
394,847
-61,169
| -13% | -$2.59M | ﹤0.01% | 1734 |
|
|
2015
Q4 | $23.3M | Sell |
456,016
-15,265
| -3% | -$778K | 0.01% | 1512 |
|
|
2015
Q3 | $22.1M | Sell |
471,281
-264,839
| -36% | -$16M | 0.01% | 1534 |
|
|
2015
Q2 | $45.9M | Buy |
736,120
+11,740
| +2% | +$731K | 0.01% | 898 |
|
|
2015
Q1 | $44.7M | Sell |
724,380
-95,892
| -12% | -$5.69M | 0.02% | 879 |
|
|
2014
Q4 | $44.3M | Buy |
820,272
+46,146
| +6% | +$2.52M | 0.02% | 907 |
|
|
2014
Q3 | $41M | Buy |
774,126
+7,398
| +1% | +$376K | 0.01% | 943 |
|
|
2014
Q2 | $39.8M | Sell |
766,728
-1,344
| -0.2% | -$64.8K | 0.01% | 951 |
|
|
2014
Q1 | $36M | Sell |
768,072
-3,344
| -0.4% | -$158K | 0.01% | 924 |
|
|
2013
Q4 | $33.9M | Sell |
771,416
-34,432
| -4% | -$1.43M | 0.01% | 965 |
|
|
2013
Q3 | $31M | Buy |
805,848
+94,524
| +13% | +$3.57M | 0.01% | 960 |
|
|
2013
Q2 | $25.1M | Buy |
+711,324
| New | +$24M | 0.01% | 1045 |
|
Other funds holding XPH
KWM
FCBT
Bank of America's XPH Position: Q1 2026 in Review
Bank of America increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 128% in Q1 2026, buying an estimated $25.4M and bringing the position to 811,939 shares worth $43.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1690.
Bank of America first reported a position in XPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.9M in Q2 2015. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.
- Bank of America held 811,939 shares of State Street SPDR S&P Pharmaceuticals ETF worth $43.9M as of Q1 2026.
- Bank of America bought 455,802 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2026, an estimated $25.4M.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1690 holding.
- Bank of America first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
- Bank of America's State Street SPDR S&P Pharmaceuticals ETF position peaked at $45.9M in Q2 2015.
- 82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.